Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
581.00 JPY | +5.25% | +4.87% | +9.42% |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 13.2B | 12.56B | 15.27B | 18.71B | 23.25B | |||||
Total Revenues | 13.2B | 12.56B | 15.27B | 18.71B | 23.25B | |||||
Cost of Goods Sold, Total | 2.07B | 2.08B | 2.49B | 3.16B | 3.93B | |||||
Gross Profit | 11.13B | 10.48B | 12.78B | 15.55B | 19.32B | |||||
Selling General & Admin Expenses, Total | 6.88B | 6.99B | 8.86B | 10.6B | 13.21B | |||||
Provision for Bad Debts | 23M | 48M | 2M | 37M | 40M | |||||
Depreciation & Amortization - (IS) | 550M | 650M | 638M | 620M | 690M | |||||
Other Operating Expenses | -98M | -69M | -5M | -10M | -71M | |||||
Other Operating Expenses, Total | 7.36B | 7.62B | 9.5B | 11.24B | 13.87B | |||||
Operating Income | 3.78B | 2.86B | 3.28B | 4.31B | 5.45B | |||||
Interest Expense, Total | -7M | -7M | -6M | -10M | -13M | |||||
Interest And Investment Income | 1M | - | 1M | 1M | 1M | |||||
Net Interest Expenses | -6M | -7M | -5M | -9M | -12M | |||||
Income (Loss) On Equity Invest. | - | - | - | -3M | -4M | |||||
Currency Exchange Gains (Loss) | 31M | -10M | 35M | 2M | -13M | |||||
Other Non Operating Income (Expenses) | - | 1M | -1M | - | - | |||||
EBT, Excl. Unusual Items | 3.8B | 2.85B | 3.31B | 4.3B | 5.42B | |||||
Impairment of Goodwill | - | 76M | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | -129M | -4M | |||||
Asset Writedown | - | -3.99B | - | 31M | 12M | |||||
EBT, Incl. Unusual Items | 3.8B | -1.07B | 3.31B | 4.2B | 5.43B | |||||
Income Tax Expense | 1.13B | 889M | 1.04B | 1.27B | 1.63B | |||||
Earnings From Continuing Operations | 2.67B | -1.96B | 2.27B | 2.93B | 3.8B | |||||
Net Income to Company | 2.67B | -1.96B | 2.27B | 2.93B | 3.8B | |||||
Minority Interest | - | -6M | -4M | - | - | |||||
Net Income - (IS) | 2.67B | -1.96B | 2.26B | 2.93B | 3.8B | |||||
Net Income to Common Incl Extra Items | 2.67B | -1.96B | 2.26B | 2.93B | 3.8B | |||||
Net Income to Common Excl. Extra Items | 2.67B | -1.96B | 2.26B | 2.93B | 3.8B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 24.02 | -18.05 | 20.92 | 27.85 | 36.54 | |||||
Basic EPS - Continuing Operations | 24.02 | -18.05 | 20.92 | 27.85 | 36.54 | |||||
Basic Weighted Average Shares Outstanding | 111M | 109M | 108M | 105M | 104M | |||||
Net EPS - Diluted | 24.02 | -18.05 | 20.92 | 27.85 | 36.45 | |||||
Diluted EPS - Continuing Operations | 24.02 | -18.05 | 20.92 | 27.85 | 36.45 | |||||
Diluted Weighted Average Shares Outstanding | 111M | 109M | 108M | 105M | 104M | |||||
Normalized Basic EPS | 21.37 | 16.3 | 19.09 | 25.53 | 32.59 | |||||
Normalized Diluted EPS | 21.37 | 16.3 | 19.09 | 25.53 | 32.51 | |||||
Dividend Per Share | 3 | 3 | 3.5 | 4 | 6.5 | |||||
Payout Ratio | 7.53 | -16.96 | 14.32 | 12.9 | 10.95 | |||||
Supplemental Items | ||||||||||
EBITDA | 4.59B | 3.77B | 4.21B | 5.33B | 6.73B | |||||
EBITA | 3.78B | 2.86B | 3.28B | 4.31B | 5.45B | |||||
EBIT | 3.78B | 2.86B | 3.28B | 4.31B | 5.45B | |||||
Effective Tax Rate - (Ratio) | 29.76 | -83.16 | 31.52 | 30.22 | 30.03 | |||||
Normalized Net Income | 2.38B | 1.77B | 2.06B | 2.69B | 3.39B | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 3.48B | 3.08B | 4.4B | 4.98B | 5.72B | |||||
Selling and Marketing Expenses | 3.48B | 3.08B | 4.4B | 4.98B | 6.34B | |||||
Research And Development Expense From Footnotes | 1M | - | - | - | - |